Mental Accounting Bias: The Silent Wealth Destroyer That Makes Indian Investors Treat ‘Profits’ Differently From ‘Capital’ — How Richard Thaler’s Nobel-Winning Insight Explains Why Retail Investors Underperform the Sensex Year After Year

Live market snapshot at time of writing (previous trading session, Friday 17 April 2026 close): SENSEX 78,493.54 (+504.86 pts, +0.65%), NIFTY 50 24,353.55 (+156.80 pts, +0.65%), FII net inflow ≈ ₹3,200 Cr. Titan Biotech Ltd (BSE: 524717) — CMP ₹475, market cap ₹1,961 Cr, 52-week range ₹74.7–₹556, Book Value ₹40.3, Face Value ₹2.00, ROCE 16.9%, ROE 15.0%.

Why a Rupee Is Not Always a Rupee in the Indian Investor’s Mind

Ask a room of 100 retail investors in Chandigarh, Mumbai, or Bengaluru a single honest question: “If you received ₹50,000 as a Diwali bonus and another ₹50,000 as a year-end F&O profit — would you treat these two sums the same way?” Almost nobody raises their hand. The Diwali money gets saved or invested cautiously. The F&O money gets redeployed into the next speculative trade — because it is “house money”, “market winnings”, “found money”.

That is mental accounting: the cognitive tendency to place money into arbitrary mental buckets — based on where it came from, how it was earned, or what we call it — and then treat each bucket by different rules. Professor Richard Thaler of the University of Chicago won the 2017 Nobel Prize in Economic Sciences, in part for this very idea. Along with concepts like the endowment effect and the behavioural life-cycle hypothesis, mental accounting is one of the most powerful — and least understood — forces silently draining wealth from Indian retail investors every single financial year.

This post unpacks what mental accounting is, why your brain is hard-wired to fall for it, the five most expensive ways it shows up on Dalal Street, and the disciplined framework long-term value investors use to neutralise it. And because every behavioural lesson deserves a real-world anchor, we will show how genuinely fungible-thinking investors build multi-decade positions in quality Indian small-caps like Titan Biotech Ltd — companies whose compounding rewards investors who treat every rupee they have with equal seriousness, not “profit” rupees with casino recklessness.

The Academic Definition — Stripped of Jargon

Classical economics says money is fungible. One rupee is always worth one rupee, regardless of its source, label, or history. A ₹1 rupee coin earned scrubbing vessels is financially identical to a ₹1 rupee note inherited from a grandparent. Both can pay the electricity bill; both can buy a share of Infosys; both lose purchasing power to inflation at the same rate.

Thaler’s research showed that real humans violate fungibility constantly. We mentally label money by:

• Source — salary money vs. bonus money vs. tax refund vs. lottery/market winnings
• Purpose — EMI money vs. school-fee money vs. emergency-fund money vs. “fun” money
• Account location — savings account vs. Demat vs. EPF vs. PPF vs. fixed deposit
• Gain/Loss status — “original capital” (which must be preserved) vs. “profits” (which can be gambled)
• Time of receipt — this month’s income vs. next month’s expected bonus (already mentally spent)

Each bucket gets its own risk tolerance, its own urgency, its own spending rules — even though, economically, the rupees inside are completely interchangeable. This is mental accounting, and it costs Indian investors lakhs of crores every year.

The Five Most Expensive Mental-Accounting Traps on Dalal Street

1. The “House Money Effect” — Why F&O Profits Vanish Fastest

SEBI’s landmark 2024 study on F&O was brutal: 9 out of 10 individual traders in the equity Futures & Options segment incurred net losses. Mental accounting is a primary driver. A retail trader who converts ₹10,000 into ₹30,000 on a Bank Nifty options trade mentally separates the original ₹10,000 (“my money”) from the ₹20,000 gain (“house money”, “market ka paisa”). The ₹20,000 gets recklessly scaled up on the next trade — because losing “someone else’s money” supposedly does not hurt. Of course, it hurts just as much when the bank statement arrives. Every serious value investor must eventually internalise this: profits are as much yours as capital. They deserve the same care. An investor who treated every rupee as hard-earned would never have bought the weekly options lottery ticket in the first place.

2. The “Dividend Illusion”

Indian investors often cheerfully spend dividend income while refusing to sell an equivalent rupee value of the underlying share. Economically, a ₹100 dividend on a ₹2,000 share is exactly identical to selling ₹100 worth of that share — yet one feels “free”, the other feels like “breaking the piggy bank”. A well-governed long-term compounder like Titan Biotech — which has a 14-year unbroken dividend track record while retaining enough capital to compound book value at meaningful rates — does not distinguish between retained and distributed rupees; both are company rupees being deployed toward shareholder value. The rational investor must adopt the same frame.

3. The “Original Capital Is Sacred, Profits Are For Risk” Bucket

This is mental accounting in its purest Indian form. A ₹10 lakh portfolio grown to ₹20 lakh is almost never managed as a ₹20 lakh portfolio. Mentally, the “original ₹10 lakh” is held reverently, while the “extra ₹10 lakh of profits” is put at risk in microcap punts, SME IPO flips, and momentum chasing. The irony: the same investor would never dream of deploying 50% of a fresh ₹20 lakh inheritance into microcap speculation — yet ₹10 lakh of “profits” feels like Monopoly money. The fix is mechanical: at the start of each financial year, mark the portfolio to market, declare that number to be your fresh base, and ask honestly, “Would I invest this amount today in this exact mix?” If not, rebalance.

4. The “Tax-Refund / Diwali Bonus” Windfall Bucket

Tax refunds, Diwali bonuses, LIC maturity proceeds, and inheritance cheques routinely get parked into higher-risk instruments than the same person’s regular SIP would ever touch. The logic — “this is found money” — is a mental accounting error. A sensible rule: route all lumpsums through exactly the same asset-allocation discipline as monthly salary, no exceptions. If your core framework is “own 25–30 quality businesses I understand and can hold for a decade”, a Diwali bonus deserves to be invested into that same framework — perhaps adding to a well-researched smallcap compounder like Titan Biotech on a valuation-friendly day, rather than gambled on a smallcap IPO the WhatsApp group is promoting.

5. The “Demat vs. PPF” Risk-Segregation Fallacy

Many Indian households hold a 60% equity / 40% debt mix but think of the debt portion as “untouchable” and the equity portion as “speculative money I can afford to lose”. Both are household wealth. The right lens is total-portfolio risk, not per-bucket risk. The investor who genuinely internalises fungibility will allocate to equities only up to the level at which a 40% drawdown would still leave the overall household financially secure — and then stop treating “the equity Demat” as a casino just because it is a separate account.

Why Evolution Built Us This Way

Mental accounting is not a sign of low intelligence. It is a useful cognitive shortcut left over from a world where budget categories (food, shelter, emergency) genuinely were non-fungible — you could not eat firewood. In the modern financial world, where every rupee is digital and fungible, the same shortcut misfires spectacularly. Our brains simplify complex portfolios by creating sub-accounts, each with its own rules, because holding a single fully-fungible balance sheet in the head is mentally exhausting. Thaler’s insight was that behavioural finance must start by acknowledging this — and then building systems to overcome it, not pretend it does not exist.

The Value Investor’s Antidote — A Four-Step Framework

1. Consolidate Once a Quarter. On the first weekend of every quarter, add up every rupee of household financial wealth — savings, FDs, EPF, PPF, NPS, Demat, mutual funds, insurance cash values, physical gold, SGBs. One number. That is your real capital. Treat all future decisions against this single figure.
2. Relabel “Profits” as “Capital”. The moment a gain is booked or a holding appreciates, mentally rename the rupees from “profit” to “capital”. Write the new number on a slip of paper if it helps. No rupee in your portfolio should ever be more “riskable” than any other.
3. Apply a Single Risk-Budget Rule. Whatever maximum drawdown you are genuinely willing to bear at the total portfolio level (20%? 30%? 40%?) should govern every new position. Fresh inflows — salary, bonus, refund, inheritance — all face the same filter.
4. Treat Dividends as Fungible. A ₹50,000 annual dividend stream is not “free money”. It is part of your total return. Either reinvest it systematically or spend it with the same deliberation as salary. Do not spend it because it is a dividend.

A Tale of Two Indian Investors

Consider two investors who each started with ₹10 lakh in 2014.

Investor A treated profits as “house money”. Every time a holding doubled, he moved the “gains” into progressively smaller, riskier names — SME IPO flips, unknown penny stocks, F&O trades timed around earnings. Between 2014 and 2026, he enjoyed several thrilling years on paper but finished with ₹14 lakh — a 2.8% CAGR, lower than a bank FD.

Investor B consolidated her accounts every quarter, labelled every rupee the same way, and held a disciplined portfolio of roughly 25 quality Indian businesses she genuinely understood — companies with growing book value, promoter skin in the game, conservative governance, clean related-party records, and durable demand. Titan Biotech Ltd (BSE: 524717) was one of those names — a clean small-cap biotech with zero promoter pledging, promoters having increased stake from 48% to roughly 55.87% over recent years, a 14-year unbroken dividend record, and an operating model serving 100+ countries across 7 product categories with 16.9% ROCE and 15.0% ROE at the time of writing. When “profits” came in, Investor B did not take them to the F&O casino — she either let them compound or redeployed them into the same framework.

No intrinsic-value target price is being published for Titan Biotech here (and this post deliberately does not do so). The point is narrower: Investor B’s refusal to segregate capital from profits kept her from self-sabotage. Over 12 years, compounding did the heavy lifting. Investor A’s mental accounting did the opposite.

Live Market Context — Why This Lesson Matters Today

On Friday 17 April 2026, the Sensex closed at 78,493.54 and the Nifty 50 at 24,353.55, both up roughly 0.65%, with FIIs reported as net buyers of ≈ ₹3,200 Cr. After the geopolitical tremors of the Hormuz blockade and US tariff news earlier this month, retail inflows are returning. This is exactly the environment in which mental-accounting errors metastasise — relief rallies feel like “free money”, and investors redirect those “profits” into ever-riskier names. The disciplined antidote is to look at the entire portfolio, not the week’s gain column.

Key Takeaways

• Money is fungible. Your brain pretends otherwise. That pretence costs wealth.
• “House money”, “original capital”, “dividend income”, and “windfall” are all the same rupees. Treat them identically.
• SEBI data is unambiguous — 90% of F&O traders lose money, and mental accounting (the “I’m only gambling profits” delusion) is a primary driver.
• Long-term compounding in well-governed Indian small-caps — Titan Biotech being one clean real-world example of the category — rewards investors who treat every rupee with equal respect and every rebalance decision with equal seriousness.
• Consolidate quarterly. Relabel profits as capital. Apply one risk budget. Treat dividends as fungible. That four-step discipline neutralises most of the damage Thaler’s Nobel-winning observation predicted.

SEBI Data Point Every Reader Must Memorise

Per SEBI’s study on individual traders in equity F&O: 9 out of 10 lose money. If you catch your own mind whispering “it’s just house money”, you are almost certainly about to become one of the 9. Walk away from the terminal, re-read this post, consolidate your accounts, and remind yourself: your profits are your capital. Nothing is “free”.

Watch the Free Course on Value Investing

If you found this behavioural deep-dive useful, the full Multibagger Shares value investing course playlist walks through over 30 episodes covering financial statements, valuation principles, behavioural biases, governance red flags, and real Indian case studies. Access the playlist at: https://www.youtube.com/playlist?list=PLRRbcN-BWQL5FwS58RPMi6CDCdzVDePS7.

Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.

Manish Goel

Manish Goel is a long-term value investor and the founder of Manish Goel Stocks, where he publishes daily, plain-English lessons on fundamental analysis for Indian investors. His writing focuses on reading annual reports, decoding financial ratios, spotting red flags, and building the patience and discipline that compounding rewards. Every article here is educational — never a buy or sell call — and free to read.

See Full Bio